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ABSTRACT 
 
Salvia divinorum is a hallucinogenic herb from the mint family, Lamiaceae. 
An estimated 1.8 million people over the age of 12 have used S. divinorum in 
their lifetime as of 2008. The abuse of S. divinorum is attractive to teens and 
young adults who wish to experiment with psychoactive materials. The plant 
material and extracts are widely available via the Internet, and it is known that S. 
divinorum will not show up on common drug screens. 
The active component in S. divinorum is salvinorin A, which is a non-
nitrogenous diterpene that is a highly selective kappa opioid receptor (KOR) 
agonist, reported to be the most potent naturally occurring hallucinogen. Since 
salvinorin A is such a selective and potent agonist of the KOR, there is interest in 
researching analogues in efforts to develop and understand therapeutic drugs for 
depression, schizophrenia, and other mental illnesses, resulting in the discovery 
of analogues with increased potency. These semi-synthetic salvinorin analogues 
have been abused by spraying the drug on innocuous plant material or on 
cigarette papers as a substrate for smoking. This practice poses a significant 
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health risk, as most new analogues will have little safety and toxicity data 
associated with common abuse routes.  
Chemical characterization of the potent analogue, salvinorin B 
ethoxymethyl ether (SB-EME) was performed in order to develop methods of 
differentiation from Salvia divinorum and salvinorin A. These characterization 
techniques include HPLC, UV/Vis, NMR, and a colorimetric assay with Ehrlich’s 
reagent. Adulteration of other plant materials with salvinorin A and analogues 
was performed and analyzed to determine if fortified materials can be detected 
by colorimetric assay.  
The validation studies of the HPLC method for SB-EME were found to be 
accurate (%RE < 12%), precise (RSD = 12%), and linear (R2 = 0.9993) over the 
mass range of 0.038 µg – 4.8 µg. The LOD was determined to be 0.038 µg, and 
the LOQ was determined to be 0.113 µg. Significant matrix effects were 
observed when using Salvia officinalis as a blank matrix, affecting the accuracy 
and selectivity of the method. However, the purified solutions of SB-EME had 
baseline resolution from salvinorin A and salvinorin B, which allows for easy 
qualitative distinction if adulterated samples are suspected.  
UV/Vis analysis provided a rapid and facile SB-EME characterization 
method. The UV/Vis trace for SB-EME was distinguishable from both salvinorin A 
and salvinorin B. NMR analysis confirmed the structures of salvinorin A, 
salvinorin B and SB-EME, with resonances specific to each compound.  
 
 
viii 
The colorimetric assay with Ehrlich’s reagent provided a red-orange result 
with salvinorin B and SB-EME, similar to salvinorin A. While this does not provide 
differentiation in the field, it does allow all materials related to Salvia divinorum to 
be identified and collected for further analysis in the lab, as this colorimetric 
analysis allows easy distinction from common kitchen herbs such as mint, basil, 
and sage. Characterization of the colored species in the assay with Ehrlich’s 
reagent was performed with UV/Vis, HPLC, and NMR. The UV/Vis analysis 
showed a new peak at 500 nm in the aqueous layer, which would correspond to 
a red-orange color. HPLC analysis revealed a new, highly retained peak from the 
DCM layer of the assay. 1H NMR analysis indicated that the backbone of the 
salvinorins was not stable in acid, and the molecule that creates the color was 
likely a degraded analogue.  
The analysis of the adulterated plant materials by colorimetric assay was 
inconclusive, as color intensity decreased as concentration of spiked standard 
increased. HPLC analysis of the vial remnants after the colorimetric assay 
confirm recoveries of the spiking compounds up to an average of 22% for 
salvinorin A, 96% for salvinorin B, and 41% for SB-EME over all matrices, 
indicating incomplete deposition of standard material onto the plant material. 
In conclusion, salvinorin B ethoxymethyl ether can be detected in the field 
through the use of Ehrlich’s reagent as a colorimetric assay. Further laboratory 
tests, including HPLC and UV/Vis, were shown to easily distinguish the ether 
derivative from salvinorin A and B. 
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1. INTRODUCTION 
1.1. Background of Salvia divinorum  
Salvia divinorum is an herb from the mint family, Lamiaceae (1). The 
Salvia genus contains a variety of herbs that are commonly known as sage. S. 
divinorum originates from Oaxaca, Mexico and is known to play a role in spiritual 
ceremonies of the Mazatecs due to the herb’s psychoactive properties (2). The 
plant is typically chewed or brewed into a tea for these ceremonies (1). 
Consumption of S. divinorum produces vivid hallucinations and has been 
traditionally used to treat anemia, headache, rheumatism, and diarrhea, among 
other ailments (3).  
S. divinorum is a green leafy plant, with large, spade-shaped leaves, 
hollow square stems and white flowers with purple calyces (see Figure 1) (4). 
The plant rarely flowers or sets seed, therefore it is mainly propagated through 
stem cuttings (2).  
 
Figure 1. Salvia divinorum. Image source: Babu et al. (5). 
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1.2. Abuse Potential 
Due to its hallucinogenic properties, this herb has a high potential for 
abuse. It is commonly known as “salvia,” “diviner’s sage,” “Maria pastora,” “Sally-
D,” “purple sticky,” and “magic mint” (4). The effects are reported to include 
hallucinations of bright lights, vivid colors, and object distortions. Uncontrollable 
laughter, fear, and other hallucinations have also been described (4). An 
estimated 1.8 million people over the age of 12 have used S. divinorum in their 
lifetime as of 2008 (6). In 2011, the “Monitoring the Future” survey reported 5.9% 
of 12th graders had used S. divinorum in the past year (6). 
There are many factors that make S. divinorum attractive as a drug of 
abuse. The plant material and extracts are widely available via the Internet, 
“head shops,” and some retail stores. Many websites will provide tips for 
cultivation, extraction of the psychoactive components, and methods of use (7). It 
is widely known that S. divinorum is not tested for on common drug screens, 
such as the National Institute on Drug Abuse 5 panel, which tests for cocaine, 
marijuana, amphetamines, opiates and phencyclidine (5, 8). The regulation of S. 
divinorum is not consistent; for example, it is handled on a state-by-state basis in 
the US (9). Finally, there is a plethora of anecdotal information on the Internet 
that indicates that S. divinorum is safe to abuse recreationally (5). All of these 
factors make the use of S. divinorum attractive to teens and young adults who 
wish to experiment with psychoactive materials.  
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The abuse of S. divinorum has also been popularized through social 
media outlets and news reports of celebrity use. The Internet site, YouTube, 
allows users to post videos of any topic for public viewing. A search of “Salvia” on 
this site shows thousands of users posting videos of their experiences taking the 
drug (10). This popular outlet mischaracterizes the use of hallucinogens as safe 
and encourages their use. 
1.3. Legal Status 
S. divinorum is not federally scheduled but has been listed as a “Drug of 
Concern” by the DEA in 2004 (4, 5). Some states and countries have enacted 
various regulatory controls on Salvia divinorum and/or its active component, 
salvinorin A, ranging from the strictest Schedule I classification to simple town 
ordinances regulating possession or sale. In the United States, Alabama, 
California, Delaware, Florida, Hawaii, Illinois, Kansas, Kentucky, Louisiana, 
Maine, Maryland, Minnesota, Missouri, Nebraska, North Carolina, North Dakota, 
Ohio, Oklahoma, Tennessee, Virginia, and Wisconsin have enacted legislation 
as of July 2012 (6). For example, Brett’s Law, SB259, was enacted in 2006 in 
Delaware and lists Salvia divinorum as a Schedule I controlled substance, 
making possession, use, or consumption illegal (11). Regulatory controls have 
been enacted in other countries, such as Australia, Belgium, Denmark, Estonia, 
Finland, Italy, Japan, Spain, and Sweden (6). The synthetic analogues and by-
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products of Salvia divinorum, however, are not scheduled or specifically 
controlled by the states in the US or other countries.  
1.4. Salvinorin A 
 
Figure 2. Chemical structure of salvinorin A. 
The active component in S. divinorum, salvinorin A (Figure 2), was 
discovered by Ortega et al. in 1982 (12). Salvinorin A is a non-nitrogenous 
diterpene that is a highly selective kappa opioid receptor (KOR) agonist, reported 
to be the most potent naturally occurring hallucinogen (13). Salvinorin A is found 
in the peltate glandular trichomes underneath the leaves in concentrations 
ranging from 0.089 - 0.37% of leaf weight (3, 14). S. divinorum is frequently 
compared to LSD, however the active component is structurally dissimilar to LSD 
(Figure 3) and does not have any effect at the 5HT2A receptor, which is the 
receptor responsible for the hallucinogenic activity of LSD and other drugs (15). 
Compared to typical KOR ligands, salvinorin A is unusual in that it is not an 
alkaloid and does not contain any nitrogen atoms (16).  It was previously thought 
that the binding of opioids at the KOR required an interaction between an 
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aspartate residue of the receptor and an amino group of the opioid (3). There has 
since been much work to understand if salvinorin A interacts with the receptor 
site in a different manner, or at a different site of the KOR altogether (3). 
Salvinorin A is consistent with other KOR agonists, such as dynorphin (3), which 
produce effects such as sedation, analgesia, inhibition of GI effects, aversion, 
and depression (1).  
 
Figure 3. Chemical structure of LSD. 
The absorption of salvinorin A occurs primarily through buccal or 
pulmonary routes. Chewing the leaves produces a hallucinogenic effect with an 
onset of seconds to minutes and the effects will last up to an hour. Smoking the 
dried leaves or inhaling vaporized salvinorin A will produce hallucinogenic effects 
within seconds and last for 20 - 30 min (1). However, the analysis of the thermal 
degradation products in the smoke of salvinorin A has shown the molecule 
undergoes deacetylation and conversion to products that are not as potent at the 
KOR  (17). 
HN
N
N O
H
H
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1.5. Current Presumptive Characterization Techniques 
Characterization and analytical detection methods have been described 
for Salvia divinorum and salvinorin A in drug products to include HPLC, LC/MS, 
GC/MS, TLC/DESI-MS, IR, X-ray crystallography, and NMR (18-27). Salvinorin A 
can also be detected in biological specimens, such as human plasma, urine, 
sweat, saliva, blood, pericardial fluid, and vitreous humor by LLE or SPE coupled 
with various forms of LC/MS or GC/MS (28). Most of these techniques are 
important to satisfy the Scientific Working Group for the Analysis of Seized Drugs 
(SWGDRUG) guidelines for confirmatory testing, however many of the 
techniques are very time consuming or require expensive equipment not 
available to most forensic labs (29). It is important to explore all available 
analytical techniques to include presumptive, or screening, techniques as well. 
Proper field screening of drug materials is important to eliminate costly lab testing 
for confirmatory analysis of unrelated materials. 
The characteristics of Salvia divinorum plant materials are not distinctive 
enough to allow differentiation by anyone other than a skilled botanist. One 
method that would be useful as a screening tool is thin layer chromatography 
(TLC). This technique has been used to characterize salvinorin A and other 
compounds extracted from S. divinorum by utilizing a vanillin stain to visualize 
the spots produced (20, 30). It has been reported that salvinorin A can be 
distinguished from THC and 13 other species of Salvia based on TLC (20). 
Another screening method that has been investigated by our lab for salvinorin A 
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is UV/Vis spectroscopy. Salvinorin A was shown to absorb at 210 nm in acetone, 
and was distinguishable from co-extracted plant pigments (31). However, both 
TLC and UV/Vis analysis require extraction of the Salvia divinorum leaves prior 
to analysis, which will add time and complexity to the screening method.   
Our lab has previously developed another screening test that utilizes 
Ehrlich’s reagent as a colorimetric assay for S. divinorum (32, 33). Ehrlich’s 
reagent consists of para-dimethylaminobenzaldehyde (pDMAB, Figure 4) as a 
2% solution in ethanol:HCl (1:1). Ehrlich’s reagent is typically used as a 
colorimetric assay for LSD, which results in a deep purple color due to the 
reaction of pDMAB with the indole ring of the LSD molecule (34). The general 
procedure was modified to include the addition of dichloromethane to extract 
salvinorin A from the trichomes of the leaves first, and then three drops of 
Ehrlich’s reagent is added (33). The result is a medium to dark shade of red-
orange, which is produced in 0.5 - 2 min. This presumptive test is fairly sensitive, 
with a distinctive color result from as little as 1 mg of dried leaf material. A screen 
of other common herbs and plants from the Salvia genus showed good 
selectivity, with cross reactivity only with Salvia farinacea (mealy sage) (33). This 
colorimetric assay has the advantage that it is very quick and eliminates the need 
for an extraction step prior to analysis.   
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Figure 4. Chemical structure of para-dimethylaminobenzaldehyde. 
1.6. Other Compounds Isolated from Salvia divinorum 
 Numerous other compounds have been isolated from Salvia divinorum 
(35). Most notably, salvinorin B, which is the deacetylated version of salvinorin A, 
was found to be pharmacologically inactive at the KOR (3). The chemical 
structure of salvinorin B and over 20 other compounds isolated from Salvia 
divinorum are illustrated in Figure 5 and described in Table 1 (18, 35-40). There 
are nine major structural classes for the isolated compounds, with hardwickiic 
acid being the simplest compound with the neoclerodane backbone (structure 2, 
Figure 5). The rest of the structures can be divided into: salvinorins, which 
contain a lactone ring (structures 1 and 3, Figure 5); divinatorins, which lack a 
lactone ring (structure 2, Figure 5); salvidivins, containing an oxidized furan ring, 
γ-hydroxybutenolide (structures 4 and 5, Figure 5); and salvinicins, with a more 
extensively oxidized furan ring, dihydroxydimethoxy-tetrahydrofuran (structure 6, 
Figure 5). The biosynthetic sequence can then be hypothesized to go from 
hardwickiic acid to the divinatorins, to the salvinorins, and then to the salvidivins 
and the salvinicins (35). Other natural products have been isolated, including the 
anti-oxidant nepetoidin B (structure 7, Figure 5), the ant-repellant loliolide 
H
N
O
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(structure 9, Figure 5), and dehydrovomifoliol (structure 8, Figure 5), which is 
involved in the synthesis of plant growth inhibitors (35, 41). 
 
Figure 5. Structures of compounds isolated from Salvia divinorum. 
Salvinorin A and B are indicated by structure 1. Descriptions following in Table 1 
(35).  
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Table 1. Compounds isolated from Salvia divinorum. R-groups correspond to 
structures preceding in Figure 5 (35). 
1.7. Semi-Synthetic Derivatives 
Since salvinorin A is a selective and potent agonist of the KOR, there is 
interest in researching analogues in efforts to develop and understand 
therapeutic drugs for depression, schizophrenia, and other mental illnesses (1). 
Significant SAR experiments have been undertaken on salvinorin A, focusing on 
four main areas: the C2 acetyl group, the C4 methyl-ester, the C17 carbonyl, and 
Compound Parent Structure R1 R2 R3 R4 
Salvinorin A 1 Ac    
Salvinorin B 1 H    
Hardwickiic acid 2 H H H H 
Divinatorin A 2 H OH H H 
Divinatorin B 2 H OH OH Me 
Divinatorin C 2 H H OAc H 
Divinatorin D 2 H OH OAc Me 
Divinatorin E 2 H OH =O Me 
Divinatorin F 2 OH OH OH Me 
Salvinorin C 3 OAc OAc   
Salvinorin D 3 OH OAc   
Salvinorin E 3 OAc OH   
Salvinorin F 3 H OH   
Salvinorin G 3 =O OAc   
Salvinorin H 3 OH OH   
Salvinorin I 3 OH OH (δ-lactol) 
Salvidivin A 4 =O OH   
Salvidivin B 4 OH =O   
Salvidivin C 5 =O OH   
Salvidivin D 5 OH =O   
Salvinicin A 6 β-OMe β-OMe   
Salvinicin B 6 α-OMe α-OMe   
Nepetoidin B 7     
Dehydrovomifoliol 8     
Loliolide 9     
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the furan ring (Figure 6) (42). Salvinorin A can be synthesized, but it is currently 
more efficient to extract and purify the active compound from the leaves of S. 
divinorum and perform modifications afterwards (30, 43). Most SAR efforts have 
focused on the C2 position, as a simple hydrolysis to salvinorin B loses activity at 
the KOR (42). In addition, this location provides the easiest access to 
modification. It was found that small alkyl groups at C2 favored KOR activity, with 
methoxymethyl ether and ethoxymethyl ether groups providing potency up to 13 
times more potent than salvinorin A (Figure 7) (44). Salvinorin A has an EC50 of 
1.8 nM, salvinorin B methoxymethyl ether (SB-MME) has an EC50 of 0.40 nM, 
and salvinorin B ethoxymethyl ether (SB-EME) has an EC50 of 0.14 nM (44). 
 
Figure 6. SAR Locations on salvinorin A for probing KOR activity. 
Modifications focused at the C2 acetyl group, C4 methyl ester, C17 carbonyl and 
the furan ring (42). 
 
Abuse of the salvinorin analogues has not yet been reported in the 
literature, but accounts of use can be found on the Internet, in which SB-EME 
has been nicknamed “Symmetry” (45). The semi-synthetic salvinorins can be 
sprayed on innocuous plant material or on cigarette papers as a substrate for 
smoking. Salvinorin A has been known to be extracted from the leaves of S. 
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divinorum and sprayed back onto the original drug plant material, known as 
“fortifying” or “enhancing” (46). Applying this practice with semi-synthetic 
salvinorins poses a significant health risk, as most new analogues will have very 
little safety and toxicity data associated with common abuse routes. In addition, 
clandestinely made synthetic drugs pose a risk in introducing unknown impurities 
during the synthesis of the desired compound (47). With the ether analogues, the 
chloroalkyl ethers used as starting materials to make the ether functionality are 
fairly toxic and known carcinogens (48).    
 
Figure 7. Semi-synthetic analogues: salvinorin B methoxymethyl ether (SB-
MME) and salvinorin B ethoxymethyl ether (SB-EME).  
1.8. Scope of Thesis 
Given the public health risk involved with semi-synthetic analogues of 
salvinorin A, it is important to develop proper field and lab analytical techniques 
to identify and characterize the semi-synthetic salvinorins in forensically relevant 
media. First, salvinorin A was extracted from the dried leaves of Salvia 
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divinorum. This material was then deacetylated to salvinorin B and converted to 
the ether analogues (see Figure 8). 
 
Figure 8. Synthetic scheme of salvinorin B methoxymethyl ether (SB-MME) 
and salvinorin B ethoxymethyl ether (SB-EME) from salvinorin A. Salvinorin 
A is converted to salvinorin B by hydrolysis at the C2 position. Condensation with 
various chloroalkyl ethers provides the desired analogues. 
 
Chemical characterization of prepared analogues was performed in order 
to develop methods of differentiation from Salvia divinorum and salvinorin A. 
Characterization techniques include HPLC, UV/Vis, NMR, and a colorimetric 
assay with Ehrlich’s reagent. Finally, adulteration of other plant materials with 
salvinorin A and analogues was performed and analyzed to determine if fortified 
materials can be detected by colorimetric assay.  
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2. METHODS 
2.1. Analytical Methods 
2.1.1. TLC 
Using vanillin as a developing stain, extractions and reactions were 
monitored by TLC. The stain was made by dissolving 6 g of vanillin (Alfa Aesar, 
99%) into 95 mL of EtOH (EMD, OmniSolv), followed by 1.5 mL of H2SO4 
(Sigma-Aldrich, reagent grade). The solution was stored at 5ºC and shielded 
from light until use. To develop the glass TLC plates, approximately 3 µL of a 1 
mg/mL solution was spotted onto the plate and ran in 10% acetone/DCM (EMD, 
HPLC grade/Alfa Aesar, ACS grade). Once the solvent was evaporated, the plate 
was dipped into the vanillin stain and the excess was wiped off. The plate was 
then heated at 60 ºC until a color developed. The compounds of interest were 
stained red with this procedure, with a yellow-green background (see Appendix 
A.1).  
2.1.2. UV/Vis 
Analysis by UV/Vis was performed on a Thermo Scientific Multiskan GO 
with SkanIT Software (Thermo Scientific, V. 3.2.0.35). Analysis was performed in 
a quartz 2 mL cuvette. The test parameters were set for fast measurement mode 
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with 1 scan per nm, spanning 200 to 1000 nm. All measurements were evaluated 
after a subtraction from the solvent blank. 
2.1.3. HPLC 
Based on a method developed by Hock et al. (25) HPLC was performed 
using an Agilent 1200 series HPLC equipped with an ultraviolet diode array 
detector, an autosampler, and Chemstation software (Agilent, V. C.01.04). The 
HPLC column was an Agilent Zorbax SB-C18 column (4.6 x 75 mm, 3.5 µm 
particle size, C18 guard column). The mobile phase was an isocratic elution of 
acetonitrile:water (45:55) at 1.0 mL/min, with a 10 min runtime. The injection size 
was 75 µL and the column temperature was set at 30ºC. Detection was 
performed at 208 nm (4 nm bandwidth, 700 nm reference). Salvinorin A eluted at 
5.76 min, salvinorin B eluted at 2.33 min, and SB-EME eluted at 6.44 min. 
2.1.4. NMR 
1H NMR spectroscopy was performed on a Bruker AVANCE-400 NMR 
Spectrometer (400 MHz) and a Bruker AVANCE-600 NMR Spectrometer (600 
MHz), located at the Massachusetts Institute of Technology Department of 
Chemistry Instrumentation Facility. Both instruments were equipped with a 
Magnex Scientific superconducting magnet, and the data was collected on 
TopSpin 3.1 software. The chemical shifts were referenced to the residual 
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solvent peaks of CDCl3 at 7.26 ppm. Data processing was performed on 
MestReNova (V. 8.0.2-11021). 
2.2. Extraction 
The extraction proceeded based on a method developed by Smith et al.  
(49). Approximately 50 g of dried Salvia divinorum leaves (Botanical Spirit Shop, 
Surrey, BC, Canada) (50) were placed into a 2 L Erlenmeyer flask, followed by 1 
L of DCM (Alfa Aesar, ACS grade). An overhead stirrer (Heidolph Electronic 
Overhead Stirrer, RZR 2102) with a PTFE stirrer blade was used to vigorously 
stir the solution for 5 minutes. The DCM was decanted over packed celite (Fisher 
Science Education) in a sintered glass funnel (VWR, 40M). Additional DCM (500 
mL) was added, and the leaves were extracted for 5 minutes and filtered as 
above. A final addition of DCM (500 mL) was added to total three extractions and 
filtrations for the portion of leaves. The extracts were combined and reduced 
under rotary evaporation (Büchi Rotavapor R-205 with heating bath) to a dark 
green residue (0.84 g crude weight). Approximately 10 mL of EtOH (EMD, 
OmniSolv) were added to the residue and allowed to stir for 24 hours with a stir 
bar. A light tan solid was filtered (Whatman, qualitative 125 mm) from the green 
solution, rinsing with EtOH, and washed with hexanes to yield 173 mg of 
salvinorin A (89% pure by HPLC). The material was brought forward with no 
further purification. Rf = 0.54 (10% acetone/DCM, developed with vanillin); 1H 
NMR (600 MHz, Chloroform-d) δ 7.41 (s, 1H), 7.39 (s, 1H), 6.37 (s, 1H), 5.53 
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(dd, J = 11.7, 4.9 Hz, 1H), 5.17 – 5.11 (m, 1H), 3.73 (s, 3H), 2.75 (dd, J = 10.6, 
6.2 Hz, 1H), 2.51 (dd, J = 13.4, 5.1 Hz, 1H), 2.36 – 2.27 (m, 2H), 2.20 – 2.13 (m, 
5H), 2.07 (dd, J = 11.7, 2.6 Hz, 1H), 1.79 (d, 1H), 1.62 – 1.56 (m, 3H), 1.45 (s, 
3H), 1.12 (s, 3H). 
2.3. Synthesis 
2.3.1. Salvinorin B 
The synthesis of salvinorin B was performed according to Munro’s 
dissertation (30). Salvinorin A (150 mg, 0.347 mmol) and sodium carbonate (ACS 
grade, 131 mg, 1.23 mmol) were added to a vial, followed by MeOH (EMD, 
Omnisolv, 3.1 mL). The solution was stirred for 24 hours at room temperature. 
The solvent was reduced under rotary evaporation, dissolved in DCM (12 mL), 
and washed with 2 N HCl (3 x 10 mL) in a separatory funnel. The aqueous layer 
was back-extracted with DCM (1 x 5 mL). The combined organic extracts were 
washed with brine (1 x 10 mL) and dried over Na2SO4. The yellow solution was 
filtered over celite and reduced under rotary evaporation to a light yellow powder. 
The solid was triturated with MeOH (5 mL) and filtered to yield 82 mg of 
salvinorin B as a white crystalline powder (93% pure by HPLC). Rf = 0.38 (10% 
acetone/DCM, developed with vanillin); 1H NMR (600 MHz, Chloroform-d) δ 7.42 
(s, 1H), 7.40 (s, 1H), 6.38 (s, 1H), 5.58 (dd, J = 5.1 Hz, 1H), 4.08 (dd, 1H), 3.72 
(s, 3H), 3.60 (d, J = 3.2 Hz, 1H), 2.71 (dd, J = 13.5, 3.0 Hz, 1H), 2.54 (dd, J = 
13.3, 5.1 Hz, 1H), 2.48 (ddd, J = 13.3, 7.6, 3.1 Hz, 1H), 2.22 – 2.12 (m, 2H), 2.11 
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– 1.98 (m, 2H), 1.79 (dt, 1H), 1.72 – 1.61 (m, 1H), 1.56 (d, J = 12.6 Hz, 2H), 1.48 
(s, 3H), 1.10 (s, 3H). 
2.3.2. Salvinorin B Methoxymethyl Ether 
Salvinorin B (25 mg, 57.0 µmol) was dissolved in 450 µL of DMF (J.T. 
Baker, ACS grade), followed by Hünig’s base (Acros Organics, 99.5%, 50 µL, 
287 µmol) and chloromethyl methyl ether (technical grade, 28 µL, 291 µmol), 
following the procedure from Munro (44). The tan slurry was stirred at room 
temperature for 72 hours. TLC indicated only 40% conversion. The solution was 
diluted with EtOAc (3 mL) and washed with 2 N HCl (3 x 3 mL), water (2 x 3 mL), 
saturated NaHCO3 (2 x 3 mL), and brine (1 x 3 mL), then dried over Na2SO4. The 
solution was filtered and reduced under rotary evaporation to a yellow residue. 
Approximately 43% starting material remained by HPLC; therefore, final 
characterization was abandoned due to the limited amount of desired product 
and significant effort required for purification.  
2.3.3. Salvinorin B Ethoxymethyl Ether 
As outlined by Munro (44), salvinorin B (24.1 mg, 57.4 µmol) was 
dissolved in 450 µL of DMF (J.T. Baker, ACS grade), followed by Hünig’s base 
(Acros Organics, 99.5%, 50 µL, 287 µmol) and chloromethyl ethyl ether 
(technical grade, 34 µL, 293 µmol). The white slurry was stirred at room 
temperature for 24 hours and deemed approximately 90% complete by TLC. The 
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solution was diluted with EtOAc (3 mL) and washed with 2 N HCl (3 x 3 mL), 
water (2 x 3 mL), saturated NaHCO3 (2 x 3 mL), and brine (1 x 3 mL), then dried 
over Na2SO4. The solution was filtered and reduced under rotary evaporation to a 
white residue. The crude solid contained approximately 10% salvinorin B and 
was purified by flash column chromatography (25-50% EtOAc/hexanes, then 
20% MeOH/DCM) to give an amorphous white solid (87% pure by HPLC). Rf = 
0.58 (10% acetone/DCM, developed with vanillin); 1H NMR (600 MHz, 
Chloroform-d) δ 7.41 (s, 1H), 7.40 (s, 1H), 6.39 – 6.35 (m, 1H), 5.55 (dd, J = 
11.7, 5.8 Hz, 1H), 4.78 (d, J = 7.2 Hz, 1H), 4.75 (d, J = 7.2 Hz, 1H), 4.17 (dd, J = 
12.2, 7.3 Hz, 1H), 3.77 – 3.65 (m, 4H), 3.65 – 3.53 (m, 1H), 2.69 (dd, J = 13.5, 
3.4 Hz, 1H), 2.53 (dd, J = 13.3, 5.2 Hz, 1H), 2.34 (ddd, J = 13.6, 7.4, 3.4 Hz, 1H), 
2.24 – 2.10 (m, 2H), 2.09 – 2.01 (m, 2H), 1.82 – 1.74 (m, 1H), 1.72 – 1.49 (m, 
3H), 1.47 (s, 3H), 1.24 (s, 3H), 1.11 (s, 3H). 
2.4. HPLC Method Validation of Salvinorin B Ethoxymethyl Ether 
2.4.1. Standard Preparation 
A 1 mg/mL solution of salvinorin B ethoxymethyl ether was diluted into 
45% acetonitrile/H2O according to Table 2. Samples were prepared in 2 mL vials 
and mixed thoroughly prior to analysis. 
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Table 2. Dilution of salvinorin B ethoxymethyl ether standards. 
Standard Volume 1 mg/mL Stock (µL) 
Volume 45% 
ACN/H2O (µL) 
Concentration 
(mg/mL) 
1 0.500 1000 0.0005 
2 1.000 999 0.0010 
3 1.500 999 0.0015 
4 2.00 998 0.0020 
5 4.00 996 0.0040 
6 8.00 992 0.0080 
7 16.00 984 0.0160 
8 32.0 968 0.0320 
9 64.0 936 0.0640 
2.4.2. Accuracy 
The accuracy of the HPLC method was evaluated by determining the 
agreement of the test concentration to the theoretical concentration, using both 
salvinorin B and SB-EME. Salvia officinalis (common sage) was used as a matrix 
blank and the standard of interest was spiked as a 2 mg/mL solution in acetone 
onto 75 mg of the dried herb to total 15 mg/g. The herb was extracted in triplicate 
with 2.0 mL aliquots of DCM for 5 min. The solution was filtered through a 0.45 
µm nylon syringe filter and rinsed with 1.0 mL of DCM. The filtered solutions were 
evaporated to dryness and reconstituted in 1 mL of acetone. The acetone 
solution was sonicated and heated to 50 ºC until a clear solution resulted. The 
solution was diluted 160 µL into 840 µL of mobile phase (45% ACN/H2O) for a 
final theoretical concentration of 0.18 mg/mL and mixed thoroughly via vortex 
before HPLC analysis.  
 
 
21 
2.4.3. Precision 
The precision of the HPLC method was evaluated by the analytical 
repeatability and intermediate precision of a set of standards. The standards 
were prepared in triplicate and injected on the previously described HPLC 
method with triplicate injections.  
2.4.4. Linearity and Range 
The linearity and range of the method was evaluated by preparing a 
standard curve for the standards prepared in section 2.4.1. The linearity was 
assessed by a best fit of the calibration response versus the concentration of the 
analyte to a linear function. The range was the interval between the upper and 
lower concentration for which precision, accuracy, and linearity was maintained. 
2.4.5. Selectivity 
Selectivity, or specificity, was evaluated by the presence or absence of 
interfering peaks in the blank matrix. The diluent and standards are also 
screened to verify matrix interference, peak carryover, or contamination of test 
solutions.  
2.4.6. Sensitivity 
Sensitivity was determined by establishing the limit of detection (LOD) and 
limit of quantitation (LOQ) for the HPLC method. The LOD is the concentration at 
which the signal-to-noise ratio (S/N) is equal to 3, and the LOQ is the 
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concentration at which the S/N is equal to 10. An average of 6 injections was 
used to calculate the S/N. 
2.5. UV/Vis Analysis of Salvinorin Derivatives 
Solutions of salvinorin A, salvinorin B, and SB-EME were made in DCM, 
each at 1 mg/mL. Each standard was diluted into seven equivalent molar 
concentrations (see Table 3) and analyzed in a 2 mL quartz cuvette on an 
UV/Vis spectrophotometer as previously described. The molar absorptivity of 
each solution and the UV/Vis spectra were gathered for each concentration. 
Table 3. Molar concentrations of salvinorin A, salvinorin B, and SB-EME. 
Sample Concentration (mmol/L) 
Salvinorin A 
(mg/mL) 
Salvinorin B 
(mg/mL) 
SB-EME 
(mg/mL) 
1 2.30 1.00 0.90 1.03 
2 1.50 0.65 0.59 0.67 
3 1.00 0.43 0.39 0.45 
4 0.50 0.22 0.20 0.22 
5 0.25 0.10 0.10 0.11 
6 0.05 0.02 0.02 0.02 
7 0.01 0.004 0.004 0.004 
2.6. Colorimetric Assay with Ehrlich’s Reagent 
2.6.1. Standard Procedure with Ehrlich’s Reagent 
The standard colorimetric assay on plant material consisted of 1 – 3 mg of 
dried leaves in a spot well, followed by the addition of 50 µL of DCM. Three drops 
of Ehrlich’s reagent was then added. Color development was present within 30 
sec, with full color development in 2 min. The assay was biphasic, with a red-
orange positive result in the top aqueous layer and a green color in the bottom 
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DCM layer. The colorimetric assay was performed on standard solutions of DCM 
at a concentration of 1 mg/mL of sample followed by 0.2 mL of Ehrlich’s reagent.  
2.6.2. UV/Vis Characterization of Colorimetric Assay  
The standard colorimetric assay was performed in a 2 mL cuvette on a 
DCM solution of salvinorin B. The path of the light for the instrument passed 
through the bottom DCM layer of the biphasic solution. UV/Vis analysis on the 
bottom DCM layer was performed by taking scans at multiple different time points 
occurring over a 30 min period. Agitation was performed by a pipette of the 
biphasic solution after 4 minutes. After 30 min the top, aqueous red-orange layer 
was removed, and UV/Vis analysis was performed on the solution. 
To determine if there was any contribution to the spectrum from just 
Ehrlich’s reagent, analysis was performed on the reagent itself. A 1:10 dilution of 
Ehrlich’s reagent was performed, diluting in EtOH, and an UV/Vis spectrum was 
taken.  
2.6.3. HPLC Characterization of Colorimetric Assay  
The DCM layer of the above colorimetric assay on a standard of salvinorin 
B and an extract of Salvia divinorum was evaporated and reconstituted in 
acetone. The acetone solution was diluted into 45% ACN/H2O and analyzed on a 
gradient HPLC method. Any attempts at working up the top, aqueous layer for 
HPLC studies quenched the color.  
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HPLC was performed using an Agilent 1200 series HPLC equipped with 
an ultraviolet diode array detector, an autosampler, and Chemstation software 
(Agilent, V. C.01.04). The HPLC column was an Agilent Zorbax SB-C18 column 
(4.6 x 75 mm, 3.5 µm particle size, C18 guard column). The mobile phase was a 
gradient elution of 35% ACN/H2O to 45% in 15 min, increase to 95% in 5 min, 
and hold for 10 min. The method was run at 1.0 mL/min, with a 30 min runtime. 
The injection size was 100 µL and the column temperature was set at 30ºC. 
Detection was performed at 208 nm (4 nm bandwidth, 700 nm reference) and 
380 nm (4 nm bandwidth, no reference). Salvinorin A eluted at 11.79 min, 
salvinorin B eluted at 4.46 min, and SB-EME eluted at 12.78 min.  
2.6.4. 1H NMR Characterization of Colorimetric Assay  
The DCM layer of a colorimetric assay on a standard of salvinorin B was 
evaporated and reconstituted in CDCl3. 1H NMR spectroscopy was performed to 
analyze the final product of the reaction in the organic layer. Any attempts at 
working up the top, aqueous layer for NMR studies quenched the color. A control 
of salvinorin B in DCM, washed with a 6N HCl and ethanol solution, was also 
analyzed to determine the effects of the presence of strong acid in Ehrlich’s 
reagent on the compounds of interest.  
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2.7. Adulteration of Plant Materials 
2.7.1. Spiking of Plant Material 
Salvinorin A, salvinorin B, and SB-EME were spiked onto dried leaves of 
Salvia divinorum, Salvia officinalis, Mitragyna speciosa (Kratom), and Calea 
zacatechichi (Dream Herb) at concentrations of 3.4 mg/g, 15 mg/g, and 40 mg/g 
in acetone. The solvent was allowed to evaporate at room temperature and 
occasionally agitated to ensure even coverage. Salvia divinorum was not spiked 
with salvinorin A, as the analysis of salvinorin A spiked Salvia divinorum has 
been previously reported (51). 
2.7.2. Colorimetric Assay of Adulterated Plant Materials 
To analyze the adulterated plant materials with Ehrlich’s reagent, 3 mg of 
each spike level from section 2.7.1 were placed on a spot well plate. Each plate 
consisted of the analysis of one type of plant material (see Table 4 as an 
example). Dichloromethane (50 µL) was added to each well, followed by 3 drops 
of Ehrlich’s reagent. Photographs were taken at 2 min.  
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Table 4. Example spot well plate setup for spiking Salvia officinalis. Three 
replicates of unadulterated S. divinorum are located in the top row as a control. 
Salvinorin A, salvinorin B, and SB-EME are spiked in each of the following rows 
at concentrations of 3.4 mg/g, 15 mg/g, and 40 mg/g. 
Spiking 
Solution 3.4 mg/g 15 mg/g 40 mg/g 
None Control  S. divinorum 
Control 
S. divinorum 
Control  
S. divinorum 
Salvinorin A 
Sal. A Spiked  
S. officinalis 
Sal. A Spiked  
S. officinalis 
Sal. A Spiked  
S. officinalis 
Salvinorin B Sal. B Spiked  S. officinalis 
Sal. B Spiked  
S. officinalis 
Sal. B Spiked  
S. officinalis 
SB-EME SB-EME Spiked  S. officinalis 
SB-EME Spiked  
S. officinalis 
SB-EME Spiked  
S. officinalis 
2.7.3. HPLC Analysis of Adulterated Plant Materials 
The vials left over from the colorimetric analysis were analyzed for 
residual active components. Acetone (1 mL) was used to rinse the vials and was 
diluted by pipetting 400 µL into 600 µL of mobile phase diluent (45% ACN/H2O). 
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3. RESULTS AND DISCUSSION 
3.1. Extraction and Synthesis 
3.1.1. Extraction and Characterization of Salvinorin A 
The extraction of salvinorin A proceeded as detailed in the literature  (25, 
30, 49). Dichloromethane was chosen as the extraction solvent of choice to 
reduce the amount of coextracted compounds and plant pigments that may 
interfere with long-term stability (49). Salvinorin A was shown to be most stable in 
dichloromethane (49), so extracts were stored at -20ºC in DCM until analysis. 
Degradation of salvinorin A was not seen by HPLC or NMR upon approximately 
6 months of storage. The approximate yield of salvinorin A from this source (50) 
of Salvia divinorum was 0.346%, which was consistent with reported values (3, 
30). The adapted HPLC method (25) showed a symmetrical peak, well resolved 
from other impurities present in the extract. Figure 9 shows a salvinorin A 
standard of 0.032 mg/mL, or 2.4 µg. Even in the commercial standard of 
salvinorin A, some salvinorin B is present. The acetone peak was introduced 
from the dilution of the standard. Regardless of the impurities present, 
characterization by 1H NMR was straightforward. A minor amount of salvinorin B 
is naturally present and was seen in both the HPLC trace and in the NMR based 
on the –OH peak. See the Appendix A.2 for the detailed 1H NMR spectra; the 
assignments match previously reported values (52). 
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Figure 9.  HPLC trace of salvinorin A standard at 2.4 µg. Some amount of 
salvinorin B was present in the commercial standard; along with an unidentified 
impurity at 7 min. Acetone was present due to the dilution procedure. 
3.1.2. Synthesis and Characterization of Salvinorin B 
Salvinorin A was deacetylated as previously described (53) with sodium 
carbonate in methanol. This reaction proceeded at room temperature with cheap, 
common reagents. This reaction could be easily performed outside of a 
laboratory environment. In addition, the trituration in methanol after work-up gave 
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an increase in purity, allowing some of the contaminants from the extraction to be 
dissolved away. The HPLC peak of salvinorin B is located in a region where 
many other compounds from the extraction elute. Salvinorin B was not 
quantifiable from the extract due to the coelution, however the final purity after 
deacetylation allows for resolution from the remaining impurities (Figure 10). The 
1H NMR spectrum shows an absence of the methyl group from the acetate 
functionality and a new peak from the resulting hydroxyl group (see Appendix 
A.3). The assignments match previously reported values (18). 
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Figure 10. HPLC trace of salvinorin B at 1.8 µg. Residual amounts of 
salvinorin A remained after deacetylation. Acetone was introduced due to the 
dilution procedure. 
3.1.3. Synthesis of Salvinorin B Methoxymethyl Ether 
Two procedures were attempted for the synthesis of salvinorin B 
methoxymethyl ether (44, 54). The reported synthesis used a catalytic amount of 
dimethylaminopyridine (DMAP) with Hünig’s base and MOM-Cl in DCM. This 
procedure was reported to be complete after 48 hours, however no conversion of 
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the starting material was seen by TLC. The second procedure mimicked the 
conditions used for SB-EME, where the solvent was DMF and no catalyst was 
used. This procedure did show some conversion but stalled after 24 hours by 
TLC. Likely the DMF was a better solvent for the reaction, but the solvent was 
not dried or distilled prior to use. Chloroalkyl ethers are relatively unstable and 
will hydrolyze readily, which is why they are used in such excess (5–fold) in these 
reactions. The presence of water would exacerbate the hydrolysis of the reagent, 
potentially consuming enough to unbalance the stoichiometry of the reaction. 
Removal of the water in the system would help drive it towards completion. Given 
clandestine chemists do not typically work with pure reagents and dry solvents, it 
was presumed more forensically relevant to proceed with the reaction with the 
reagents as is. The very low conversion of this reaction will give some insight into 
the limited likelihood this synthesis will find popularity in the field.  
The HPLC trace was difficult to analyze given more than one new peak 
appeared after the synthesis (see Figure 11). Due to the complexity of 
purification needed, further characterization of the compound was abandoned. 
Given its high potency of 0.4 nM EC50, compared to salvinorin A at 1.8 nM (44), it 
is plausible clandestine chemists would accept a mixture for recreational use. 
However, for the purposes of characterizing and identifying differentiating 
analytical techniques, material that is relatively pure would be needed to continue 
in this study. 
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Figure 11. HPLC trace of salvinorin B methoxymethyl ether. Approximately 
43% of salvinorin B starting material is present, along with three new minor 
peaks. The specific peak to SB-MME was not identified. Acetone was introduced 
during sample preparation. 
3.1.4. Synthesis and Characterization of Salvinorin B Ethoxymethyl Ether 
The synthesis of SB-EME proceeded more efficiently than the methoxy-
derivative, however the obtained yield was much lower than reported (44). This is 
also likely due to the instability of the chloroalkyl ethers (refer to section 3.1.3). It 
is hypothesized the presence of the initial water in the solvent will degrade more 
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of the chloroalkyl ether and additional equivalents should be added to 
compensate.        
 
Figure 12. HPLC trace of SB-EME at 4.8 µg. The RT of SB-EME is 6.44 min, 
achieving baseline resolution from salvinorin A, salvinorin B, and other impurities. 
 
After column chromatography, SB-EME was 87% pure by HPLC (see 
Figure 12). The resulting peak has a close retention time to salvinorin A 
(salvinorin A @ 5.76 min; salvinorin B EME @ 6.44 min); however, baseline 
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resolution is achieved. The resolution on TLC (10% acetone/DCM) was more 
difficult to establish from salvinorin A. Resolution from salvinorin B was evident. 
1H NMR analysis matched previously reported values (44). In particular, 
the disappearance of the hydroxyl peak and presence of three new sets of peaks 
corresponding to the ether methyl and two methylene groups was evident (see 
Appendix A.4).  
3.2. HPLC Method Validation Salvinorin B Ethoxymethyl Ether 
3.2.1. Accuracy 
The accuracy of the method was evaluated based on the degree of 
agreement of the test concentration to the theoretical concentration by spiking 
salvinorin B and salvinorin B ethoxymethyl ether separately onto Salvia 
officinalis. However, matrix effects from the extraction of the Salvia officinalis 
plant material in DCM limited the quantitative ability of this experiment. See 
section 3.2.4 for more discussion on the selectivity of the method. 
The spiking experiment was performed in triplicate. The results show the 
recovery of salvinorin B was approximately 88%, and the recovery of SB-EME 
was approximately 100% using this method (see Appendix A.5.1 for data table). 
However, given the known matrix issues, the error in these values is not well 
defined. Therefore, spiked material should be evaluated qualitatively until the 
effect by the matrix can be mitigated.  
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The accuracy in the prepared standards was evaluated by the percent 
relative error calculated against the generated calibration curve in Figure 13. 
Three sets of standards of SB-EME were prepared and combined into a single 
curve. The equation for the best-fit line was then used to back calculate the 
concentrations of the solutions and the error was evaluated. The raw data tables 
are located in Appendix A.5.2. The first set of standards had an absolute range 
of error from 0.03 – 11.79%, which is indicative of a fairly accurate method. 
However, the subsequent second and third sets of standards increased in 
relative error from 1.98 – 22.89% to 6.24 – 19.47%, respectively. The trend 
towards increasing error for the samples analyzed later indicates there may be a 
stability consideration for SB-EME. The analysis of the three sets of standards 
took approximately 36 hours to complete by HPLC. Salvinorin A has shown 
instability in solvents such as ACN previously (31, 49).   
3.2.2. Precision 
The precision of the HPLC method was evaluated by the analytical 
repeatability and intermediate precision of a set of standards. The standards 
were prepared in triplicate and injected on the previously described HPLC 
method with triplicate injections. Refer to Appendix A.5 for the raw data tables. 
The average areas of the triplicate preparations were graphed versus the 
concentration of the solutions in Figure 13. 
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Figure 13. SB-EME calibration curve. This data was used to determine the 
accuracy, precision, linearity, and range of the HPLC method. Error bars indicate 
standard deviations. 
 
The repeatability within each set of standards was below 9% RSD for 
triplicate injections. The intermediate precision between the three sets of 
standards was <12% RSD. An acceptable % RSD for method validation is <10%. 
The inherent error in the analytical balance was about 10% when weighing 1 mg 
of material. Given the material was very limited, weighing out 1 mg in triplicate 
will introduce a large amount of error. With this error in mind in addition to 
stability concerns, a % RSD of 12% is acceptable for this method. 
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3.2.3. Linearity and Range 
The linearity and range were assessed based on the calibration curve in 
Figure 13. The linearity was determined by the best fit of the calibration curve, 
which is 0.9993, indicating good linearity over the range of the standards. The 
range covers two orders of magnitude from 0.0005 – 0.064 mg/mL, or a mass of 
0.038 µg – 4.8 µg. Loss of linearity was not observed so this method could be 
useful for a wider range than presented here. 
3.2.4. Selectivity 
Selectivity, or specificity, of the HPLC method was evaluated by the 
presence or absence of interfering peaks in a blank matrix. Salvia officinalis was 
chosen as the matrix to use, as it does not contain any inherent salvinorin-type 
compounds found in Salvia divinorum. A spectrum of salvinorin B (15 mg/g) 
spiked onto Salvia officinalis is shown in Figure 14. Salvinorin B is apparent in 
the spectrum at 2.3 min, but does not achieve baseline resolution from the 
previous peak. Baseline resolution is the difference in retention time between two 
adjacent peaks, divided by the sum of the peak widths; a resolution greater than 
1 allows for identification of separate peaks, but a value of 1.5 or greater is 
needed for resolution down to the baseline. The resolution of the salvinorin B 
peak from the previous peak is 1.11 and is coeluting on the shoulder of the 
previous peak. This will affect the integration value of the peak, impacting the 
accuracy of the quantitation.  
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Figure 14. HPLC of salvinorin B spiked Salvia officinalis at 15 mg/g. Inset 
shows spiked sample in blue overlaid with a matrix blank in red.  
 
 The Salvia officinalis extract contains many peaks, including a significant, 
broad, tailing peak starting at 3.5 min. Salvia officinalis has been used as a 
successful matrix blank in GC/MS analyses (51), but it might not be suitable for 
HPLC analysis due to the solubility of compounds from the leaf matrix in DCM. 
Salvinorin B ethoxymethyl ether was also spiked onto Salvia officinalis at 15 
mg/g. The spectrum is shown in Figure 15. In this case, the SB-EME peak elutes 
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on the tail of the broad Salvia officinalis peak, having no resolution from the 
matrix. The presence of the SB-EME peak can be determined easily, but 
quantitation will be significantly affected. Integration was performed by drawing a 
flat baseline across the spectrum and dropping a line down on either side of the 
peak. These resolution issues will also affect the LOD these compounds, as 
trace amounts would be lost in the coeluting matrix peaks.   
 Evaluation of standards on this HPLC method shows good resolution of 
salvinorin A, salvinorin B, and salvinorin B ethoxymethyl ether from each other 
and from other impurities (see Figures 9, 10, 12, respectively). However, it will 
be important to fully evaluate any matrix effects prior to quantitative analysis on 
any plant materials. A method to clean up the plant extracts could be developed 
in order to achieve better selectivity. 
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Figure 15. HPLC of SB-EME spiked Salvia officinalis at 15 mg/g. Inset shows 
spiked sample in red overlaid with a matrix blank in blue. 
3.2.5. Sensitivity 
The LOD was determined to be 0.0005 mg/mL, or 0.038 µg of SB-EME. 
The LOQ was determined to be 0.0015 mg/mL, or 0.113 µg. The S/N values are 
reported in Table 5 and the S/N values for the entire calibration curve is found in 
Appendix A.6. 
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Table 5. LOD and LOQ determination for SB-EME. The LOD is at S/N of 3 and 
the LOQ is at a S/N of 10. 
Concentration 
(mg/mL) Set 1 S/N Set 2 S/N Set 3 S/N LOD S/N LOQ S/N 
0.0005 
3.8 4.8 3.5 
4.3 
  
4.4 4.2 3.6 
4.3 5.9 3.9 
0.0015 
10.2 10.9 9.4 
  
10.6 12.3 10.8 9.7 
12.0 12.2 7.9 
3.3. UV/Vis Analysis of Salvinorin Derivatives 
The resulting spectra of the UV/Vis analysis on the concentrations of 
salvinorin A, salvinorin B, and SB-EME standards in DCM from Table 3 are 
presented in Appendix 7, and an overlay of the highest concentration of each is 
located in Figure 16. As the extraction is performed in DCM, the solutions of 
standards are analyzed in the same solvent. This would allow for screening of 
the extracted solutions by UV/Vis prior to confirmatory analysis. Salvinorin A 
shows slight absorbance of impurities at 400 nm and 660 nm, which have been 
previously characterized (31). The remainder of the spectrum is similar to 
salvinorin B; both have absorbance maxima at 279 nm. The SB-EME spectrum 
displays a diminished absorbance at 280 nm and new absorbance at 337 nm 
relative to salvinorin A and salvinorin B; therefore, the overall trace is 
distinguishable from both salvinorin A and salvinorin B. 
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Figure 16. UV/Vis of salvinorin A, salvinorin B, and SB-EME at 2.3 mmol/L. 
Salvinorin A (red) and salvinorin B (green) have similar maxima, where SB-EME 
(purple) shows a new maxima at 337 nm. 
 
The molar absorptivities, or the strength of absorbance at a given 
wavelength, of each standard was determined by plotting the maximum 
absorbance (λmax) versus the concentration. The molar absorptivity is the value of 
the slope of the curve in units of M-1cm-1 and were calculated from using 5 of the 
standards in which the linearity was maintained. The results are presented in 
Figures 17, 18, and 19. The λmax of salvinorin A and B was chosen at 279 nm to 
avoid the interference caused by the subtraction of DCM. The UV/Vis cuttoff of 
DCM is 230 nm, below which quantitative analysis is hindered by the absorbance 
of the solvent. The molar absorptivity of salvinorin A (@279 nm) is 227.04 M-1cm-1, 
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of salvinorin B (@279 nm) is 162.33 M-1cm-1, and SB-EME (@244 nm) is 199.63 
M-1cm-1.  
 
Figure 17. Salvinorin A absorbance versus concentration at 279 nm. The 
molar absorptivity at 279 nm is 227.04 M-1cm-1. 
 
 
Figure 18. Salvinorin B absorbance versus concentration at 279 nm. The 
molar absorptivity at 279 nm is 162.33 M-1cm-1. 
y = 227.04x + 0.026 
R² = 0.98777 
0.00 
0.10 
0.20 
0.30 
0.40 
A
bs
or
ba
nc
e 
(A
U
) 
Concentration (M) 
Salvinorin A Absorbance vs. Concentration at 279 nm 
y = 162.33x + 0.0142 
R² = 0.99345 
0.00 
0.05 
0.10 
0.15 
0.20 
A
bs
or
ba
nc
e 
(A
U
) 
Concentration (M) 
Salvinorin B Absorbance vs. Concentration at 279 nm 
 
 
44 
 
Figure 19. SB-EME absorbance versus concentration at 244 nm. The molar 
absorptivity at 244 nm is 199.63 M-1cm-1. 
3.4. Colorimetric Assay and Mechanistic Studies 
3.4.1. Standard Ehrlich’s Procedure and Mechanistic Discussion 
The reaction of Salvia divinorum with Ehrlich’s reagent performed as 
previously reported (32, 33). A red-orange color developed within 30 seconds 
and was fully developed in 2 minutes (see Figure 20). 
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Figure 20. Salvia divinorum after addition of Ehrlich’s reagent. Photograph 
was taken after 2 minutes of reaction (n=6). 
 
 To understand the mechanism behind the red-orange colored result of 
Ehrlich’s reagent with Salvia divinorum, the reported mechanism of Ehrlich’s 
reagent with LSD was first examined (see scheme represented in Figure 21). 
The mechanism is reported to proceed by an electrophilic aromatic substitution of 
the indole ring from LSD with the aldehyde from pDMAB (55). The reaction goes 
through a cationic intermediate to yield a final 2:1 adduct of 2 molecules of LSD 
for every one of pDMAB. The final adduct is described as a cyanine dye (55). 
The furan ring will perform the same type of reaction with Ehrlich’s reagent as an 
indole ring since analogous heterocycles perform similar reactions (56). Figure 
22 illustrates the relative reactivities of a pyrrole ring, which is a part of an indole 
ring, to a furan ring and to a thiophene ring. These heterocycles only differ in the 
 
 
46 
electron density around the heteroatom and therefore will differ only with the rate 
of reaction.  
 
Figure 21. Reported reaction scheme of Ehrlich’s reagent with LSD. The 
aldehyde of pDMAB performs an electrophilic aromatic substitution on the indole 
ring of LSD, forming a 2:1 final adduct (55). 
 
 
 It has been reported in the literature by Kuroda et al. that Ehrlich’s reagent 
can be used to detect furan-type compounds in natural products (57). The 
resulting substituents around the heterocycle will dictate the color of the reaction  
(58). However, these authors report the colored component of the reaction is the 
cationic intermediate (Figure 23, in brackets), and not the final 2:1 adduct (57). 
The intermediate could not be isolated, and the final 2:1 adduct was not colored, 
so the authors attempted to quench the reaction to trap the intermediate. Figure 
23 illustrates the scheme the authors used to characterize the intermediate. They 
were able to isolate about 1% of the ethanol adduct for characterization by NMR. 
The rest of the reaction yielded the 2:1 adduct or decomposition products (57). 
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Figure 22. Relative heterocyclic reactivity of pyrrole, furan, and thiophene.  
 
 
Figure 23. Isolation of colored cationic intermediate from reaction of 
furanoeremophilanes with Ehrlich’s reagent. A model compound was reacted 
with pDMAB and quenched with ethanol to trap the colored intermediate. 
Characterization by Kuroda et al. (57). 
 
 It is hypothesized that the salvinorins and divinatorins (Figure 5 and Table 
1) in Salvia divinorum will react in the same way with an electrophilic aromatic 
substitution of the furan ring with pDMAB (see Figure 24). This hypothesis is 
supported by secondary experimental observations. The aqueous layer of the 
colorimetric assay is colored, in which a small cationic molecule will be soluble. 
The color is not stable and will turn to a green-blue over time, also suggesting a 
temporary intermediate is creating the color. Finally, any attempts at isolating or 
analyzing the aqueous layer quickly quench the color, which does not allow for 
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direct analysis. Since the intermediate cannot be directly characterized, efforts 
were switched to characterizing the 2:1 adduct of salvinorin A with pDMAB. If this 
adduct exists in the DCM layer of the reaction, it could be easily isolated and the 
structure determined. This could give indirect evidence that the mechanism 
proceeds through the cationic intermediate to yield the final 2:1 adduct. The 
following studies with UV/Vis, HPLC, and NMR will focus on the characterization 
of the 2:1 adduct. 
 
Figure 24. Proposed reaction scheme of salvinorin A with Ehrlich’s reagent. 
Salvinorin A undergoes an electrophilic aromatic substitution of the furan ring 
with the aldehyde on pDMAB. The intermediate of the reaction creates a red-
orange color and the final product is a 2:1 adduct.  
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Since many compounds isolated from S. divinorum contain a furan ring, all 
of the analogous structures from Figure 5 and Table 1 will react with Ehrlich’s 
reagent. This might be the reason as to why the results on 50 µg standards of 
salvinorin A produces a weaker color than 1 mg of Salvia divinorum leaves, 
which contains only 3.4 µg of salvinorin A, as shown in previous work (33). In 
addition, the cross-reactivity with Salvia farinacea (mealy sage) (33) can be 
explained by examining the known compounds isolated from that plant (see 
Figure 25). While not considered salvinorins, the compounds salvifarin and 
salvifaricin both contain a furan ring, which should perform the same chemistry 
with Ehrlich’s reagent.  
 
Figure 25. Compounds isolated from Salvia farinacea. Salvifarin and 
salvifaricin both contain a furan ring, which reacts with Ehrlich’s reagent. 
3.4.2. UV/Vis Characterization of Colorimetric Assay  
The top aqueous layer and bottom organic layer of the reaction with 
Ehrlich’s reagent were characterized by UV/Vis, using a standard of salvinorin B 
in DCM as a blank subtraction. For analyzing the bottom organic layer, the 
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solutions were placed in a narrow 2 mL cuvette and agitated via pipette after 4 
min. There was no appearance of color within the first 4 minutes, and it is 
hypothesized that the reduced surface area of the cuvette accounts for the 
slower reaction rate when compared to a spot plate. When performing the assay 
in a spot well plate, the leaves noticeably swirl around the well, providing some 
agitation. On a standard solution in a cuvette, very little natural agitation occurs 
until the solution is manually mixed. After agitation at 4 min, the red-orange color 
developed. In Figure 26, the UV/Vis spectra of the bottom, DCM layer is shown 
after multiple measurements over a 30 min time period. The spectra for the first 4 
minutes have minimal absorbance as shown in the zoomed image in Figure 27. 
The flat baseline indicates there is no change in absorbance from the reference 
standard of salvinorin B that was used as a subtraction blank. Once the solution 
is agitated, there is an immediate presence of a new absorbance profile (blue 
spectra in Figure 26 and 27). This major profile does not absorb into the visible 
region, however, indicating it is not colored. There is a slight absorbance at 500 
nm, which is the red-orange range that increases after mixing; however, the DCM 
layer is not the layer that is strongly colored.  
The drastic change in the spectra after mixing could be hypothesized to be 
the formation of the 2:1 adduct, absorbance from Ehrlich’s reagent (Figure 28), 
or formation of degradants from interaction with the HCl. In general, the 2:1 
adduct would have a combination of absorbance features from both salvinorin B 
and Ehrlich’s reagent due to the functional groups contributing to the spectrum. 
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The presence of a broader peak spanning 250 – 300 nm could encompass these 
features shown in Appendix 7.2 and Figure 28. It is also plausible that the 
spectral change could be due to the absorbance of Ehrlich’s reagent alone. The 
reaction is traditionally performed with an excess of Ehrlich’s reagent, and the 
high concentration could account for the saturation of the detector above 2.5 AU 
as seen in Figure 26. Finally, the interaction of salvinorin B with 6N HCl could 
have affected the structural integrity of the molecule. Future studies should 
include UV/Vis analysis on the salvinorin B standard with 6N HCl in ethanol. This 
would help eliminate any contribution from the high concentration of pDMAB and 
highlight the affects of the acid on the molecule.  
 
Figure 26. UV/Vis of salvinorin B in DCM layer during reaction with 
Ehrlich’s reagent. Spectra were measured multiple times over 30 min. Agitation 
of the reaction occurred after 4 min. 
 
 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
200 250 300 350 400 450 500 550 600 650 700 
A
bs
or
ba
nc
e 
(A
U
) 
Wavelength (nm) 
Salvinorin B + Ehrlich's Reagent - DCM Layer 
Initial 
34  s 
45 s 
2 min 
4 min 
7 min 35 s 
15 min 
30 min 
 
 
52 
 
Figure 27. Zoomed baseline of UV/Vis of salvinorin B in DCM layer during 
reaction with Ehrlich’s reagent. Spectra were measured multiple times over 30 
min. Agitation of the reaction occurred after 4 min. 
 
 
Figure 28. UV/Vis of Ehrlich’s reagent. 1:10 dilution in ethanol. 
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Figure 29. UV/Vis of the aqueous layer of colorimetric assay with Ehrlich’s 
reagent.  Solution was reacted for 30 min with salvinorin B. 
 
Figure 29 shows the UV/Vis trace of the top, aqueous layer after reaction 
of 30 min with salvinorin B. There is an increase in absorbance at 500 nm that is 
not present in the original reagent, as seen in Figure 28, which shows fresh 
Ehrlich’s reagent, diluted 1:10. Absorbance in the 500 nm region translates to a 
red-orange color. The small amount of absorbance at 500 nm seen in the DCM 
layer in Figure 27 could be due to incomplete separation of the layers during the 
analysis. The peak has the same profile with a maximum at 500 nm, and a 
shoulder at 550 nm.  
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3.4.3. HPLC Characterization of Colorimetric Assay  
The analysis of the DCM layer on HPLC is shown in Figure 30. The 
method was changed to a gradient method to allow for a highly retained new 
peak to elute off of the column. This compound is very non-polar and has local 
maxima at 225 nm and 275 nm. The negative peaks seen in the trace indicate 
the compound eluting off has less absorbance than the mobile phase at that 
wavelength. The presence of the new peak and the negative peaks indicates that 
some new chemistry has occurred with salvinorin B. The new peak could be the 
final 2:1 adduct, and/or the negative peaks could be quenched molecules of the 
cationic intermediate or some other byproducts. The trace does not provide any 
additional differentiation, however. 
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Figure 30. HPLC trace of DCM layer after 30 min reaction with Ehrlich’s 
reagent. Arrows indicate positions of salvinorin A and salvinorin B. 
3.4.4. 1H NMR Characterization of Colorimetric Assay  
Presuming that the colored species is located in the top aqueous layer, 
the DCM layer was analyzed by 1H NMR. The layer was separated from the acid, 
washed with NaHCO3 to neutralize the pH, dried over Na2SO4, filtered, and 
evaporated down. The residue was reconstituted in CDCl3 for 1H NMR analysis. 
A separate sample was analyzed in which salvinorin B in DCM was washed with 
6N HCl in ethanol for 30 min and worked up as before to determine how the acid 
affects the structural integrity. Figure 31 shows the NMR spectra of salvinorin B 
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standard (top, blue), the DCM layer (middle, red), and the acid-washed salvinorin 
B (bottom, green) (see Appendix A.8 for larger versions). Of note is the area 
from 6.0 ppm to 10 ppm, which contains the aromatic protons. In the salvinorin B 
standard (top, blue), three singlet peaks are seen, indicating the three protons of 
the furan ring (excluding 7.26 ppm, which is residual CHCl3). The structural 
characterization of the salvinorins has been well established in the literature, and 
the analysis here of salvinorin B was consistent with the reported results (52). No 
measurable coupling of the protons on the furan ring was seen in the standard 
solutions. In the DCM layer (middle, red) that has undergone reaction with 
pDMAB in Ehrlich’s reagent, these peaks have changed, and new peaks are 
present. There are only two peaks corresponding to the aromatic furan protons, 
and three peaks corresponding to pDMAB are now present. This is encouraging, 
since it is expected that one furan peak will disappear once reacted, and the 
pDMAB peaks will appear in the DCM layer. However, the spectrum is more 
complex than expected due to the interaction with the HCl present in Ehrlich’s 
reagent. As seen in the acid-washed spectrum (bottom, green), the same pattern 
for the two furan protons is present, indicating this is due to the interaction with 
the acid and not with reaction with pDMAB. Upon examination of the rest of the 
spectra, from 2.0 to 3.0 ppm for example, most of the other protons from the 
salvinorin B standard (top, blue) have disappeared in the DCM layer (middle, 
red), and mimic the pattern seen in the acid washed standard (bottom, green). 
These proton signals are not expected to change based on the proposed 
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mechanism. This indicates the acid has likely broken the molecule apart, which 
makes characterization more complex.  
What can be elucidated from this data is that there are still aromatic 
protons present. Of importance is that there are only two furan protons, as the 
rest are attributed to chloroform-d, or pDMAB. Since the third proton is missing, it 
likely has reacted, which supports the proposed mechanism for salvinorin A and 
related compounds. While the strong acid in Ehrlich’s reagent has destroyed the 
molecule, it is proposed that the interaction with pDMAB is still significant enough 
to still create a colored intermediate.     
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Figure 31. 1H NMR analysis of colorimetric assay with Ehrlich’s reagent. 
Salvinorin B (blue), DCM layer assay with Ehrlich’s reagent (red), and acid 
washed salvinorin B (green) spectra are shown. Left box highlights the aromatic 
region with the furan protons. Right box highlights the change of protons from the 
rest of the molecule after reaction with HCl.  
  
To determine which proton of the furan ring reacted in this reaction, a 2D 
1H correlation spectroscopy (COSY) NMR experiment was performed, using 
salvinorin B as the model compound. This experiment shows the J-coupling, or 
the interaction the magnetic spin of two adjacent protons have with each other 
(59). The COSY spectrum is shown in Figure 32 (larger version in Appendix 
A.8.4), and the indicated coupling is highlighted by a box. Symmetrical signals 
are called crosspeaks and indicate the coupling within the molecule. This 
Aromatic region 
Three furan H 
Two furan H 
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interaction of the two aromatic protons indicates they must be adjacent to each 
other, and located on the same side of the furan ring. Therefore, the final 
proposed mechanism is thought to react on the side of the furan ring with the 
single α-proton as indicated in the reaction scheme in Figure 24. 
 
Figure 32. COSY NMR of salvinorin B reacted with Ehrlich’s reagent. The 
aromatic region is expanded from 6.4 ppm to 7.9 ppm, and the interaction 
between the two furan protons is highlighted by a dotted box. 
3.5. Adulteration of Plant Materials 
3.5.1 Colorimetric Assay of Adulterated Plant Materials  
The colorimetric assay with Ehrlich’s reagent was used to determine if 
salvinorin A, salvinorin B, or salvinorin B ethoxymethyl ether could be detectable 
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on adulterated plant materials. First, a screen on the standards alone was 
performed, as seen in Figure 33. The resulting color is lighter than what was 
visualized on dried plant material as previously discussed in section 3.4.1, but all 
three produced a red-orange color.  
 
Figure 33. Colorimetric analysis of salvinorin A, salvinorin B, and SB-EME 
standards. Standards of 1 mmol/L were analyzed and allowed to react for 2 min 
prior to photograph. 
 
The lowest level of spike was 3.4 mg/g of dried leaf material, as that is the 
concentration reported in the literature of the natural Salvia divinorum plant (30). 
The next two levels, 15 mg/g and 40 mg/g, were chosen to represent an 
“enhanced regular-strength” and an “enhanced extra-strength” dose (46). The 
standards were spiked in an acetone solution and allowed to air dry on the 
leaves. Salvia officinalis was chosen to represent a matrix blank, as it has the 
same genus as Salvia divinorum and no salvinorin type compounds have been 
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previously isolated from this plant (51). Kratom and Dream Herb were chosen to 
represent a range of plant materials that were inexpensive, easily accessible, 
and known for their abuse potential (1). These two plant materials also 
represented a range of phenotypes, where Kratom was a uniform sample of 
small, dark brown broken leaves, and Dream Herb was an inhomogeneous 
sample of larger pieces of green leaves and flower buds.  
First, the colorimetric assay was performed in triplicate on all of the 
unadulterated plant materials prior to spiking to determine if any interfering colors 
or side reactions resulted. The plain leaves are pictured in Figure 34, and the 
assay with Ehrlich’s reagent on the leaves after 2 min are pictured in Figure 35. 
Salvia divinorum turns a red-orange color, as expected in the presence of 
Ehrlich’s reagent. Salvia officinalis and Kratom have no color change, with the 
solution staying yellow after addition of Ehrlich’s reagent. Dream Herb appears to 
have a more intense yellow color after the reaction. While no furan compounds 
have been isolated from Dream Herb, furanone type molecules have been 
identified (60). These structures are more complex, and therefore more empirical 
data is needed to determine if they will produce a color result with Ehrlich’s 
reagent. See Figure 36 for a representative structure from Dream Herb. 
 
 
62 
 
Figure 34. Samples of S. divinorum, S. officinalis, Kratom, and Dream Herb. 
Unadulterated leaves, prior to assay with Ehrlich’s reagent (n = 3).  
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Figure 35. Samples of unadulterated S. divinorum, S. officinalis, Kratom, 
and Dream Herb after reaction with Ehrlich’s reagent. Samples reacted for 2 
min (n = 3). 
 
 
 
Figure 36. Structure of 9α-acetoxyzexbrevin from Dream Herb. 
Stereochemistry not indicated. 
 
The reaction of adulterated Salvia divinorum is seen in Figure 37. The 
unadulterated leaves are analyzed in triplicate in the top row. Only salvinorin B 
and salvinorin B ethoxymethyl ether were spiked onto dried Salvia divinorum, 
however the color result was opposite of what was expected. With the addition of 
more furan containing compounds, the red-orange color was expected to 
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intensify. Instead, the color result decreased as the concentration of spiked 
standard increased. 
 
Figure 37. Adulterated Salvia divinorum with salvinorin B and SB-EME after 
reaction with Ehrlich’s reagent. After 2 min, the adulterated samples showed a 
less intense or negative result. The top row contained 3 replicates of 
unadulterated leaves as a control. Each column contains 3.4, 15, or 40 mg/g of 
spiking standard, respectively.  
 
It is hypothesized that this result is due to the spiking procedure used. 
Stock solutions of the standards were made in acetone, and the volume of the 
stock solution was adjusted to achieve the desired amount of additional 
compound added. This resulted in very small volumes added to the leaves for the 
3.4 mg/g spike and larger volumes added to the leaves for the 40 mg/g spike. A 
visible residue was seen in the vials of the 40 mg/g spike, indicating the extra 
solvent potentially extracted out the inherent salvinorin A in the leaves and 
deposited both salvinorin A and the spiking standard onto the glass of the vial. 
 
 
 
S. divinorum 
Unadulterated 
 
 
 
S. divinorum 
+ Salvinorin B 
 
 
S. divinorum 
+ SB-EME 
 
3.4 mg/g 15 mg/g 40 mg/g 
 
 
65 
Efforts were made to scrape out all of the contents of the vial, but the transfer 
was not quantitative.  
The spiking study was modeled after a similar study performed by Willard 
et al., where the authors spiked samples of Salvia divinorum with salvinorin A 
and analyzed by GC/MS (51). After the spiking of the samples, the vials from 
Willard were directly analyzed and extracted for GC/MS analysis, whereas the 
samples in this study were analyzed with Ehrlich’s reagent on a separate spot 
well plate. This resulted in analysis on only the plant material for this study, and 
did not include the vial or original container used to deposit the spiking standard. 
In addition, the authors only looked for the presence of salvinorin A by GC/MS 
and did not present any quantitative data on the recoveries of the spiking 
experiment. This information would be helpful to compare the point of difference 
between the two experiments. In order to evaluate this hypothesis that the 
spiking standard remained in the original vial and did not transfer to the plant 
material, the empty vials were extracted with acetone and subsequently 
analyzed. See discussion in Section 3.5.2. 
This result was also seen in all of the other spiked plant materials. Salvia 
officinalis spiked with salvinorin A, salvinorin B, and SB-EME is presented in 
Figure 38. Kratom and Dream Herb spiked samples are presented in Figures 39 
and 40, respectively. No color change was seen on any of the spiked plant 
materials after 2 minutes. If left for 10 minutes, a very slight change was seen at 
the 3.4 mg/g spike level. However, at this time all of the DCM had evaporated 
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from the S. divinorum control wells, and no red-orange color remained. 
Therefore, the slight color change cannot be read as a positive result.  
 
 
Figure 38. Adulterated Salvia officinalis with salvinorin A, salvinorin B, and 
SB-EME after reaction with Ehrlich’s reagent. After 2 min, the adulterated 
samples showed a negative result. The top row contained 3 replicates of 
unadulterated S. divinorum as a control. Each column contains 3.4, 15, or 40 
mg/g of spiking standard, respectively.   
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Figure 39. Adulterated Kratom with salvinorin A, salvinorin B, and SB-EME 
after reaction with Ehrlich’s reagent. After 2 min, the adulterated samples 
showed a negative result. The top row contained 3 replicates of unadulterated S. 
divinorum as a control. Each column contains 3.4, 15, or 40 mg/g of spiking 
standard, respectively.   
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Figure 40. Adulterated Dream Herb with salvinorin A, salvinorin B, and SB-
EME after reaction with Ehrlich’s reagent. After 2 min, the adulterated 
samples showed a negative result. The top row contained 3 replicates of 
unadulterated S. divinorum as a control. Each column contains 3.4, 15, or 40 
mg/g of spiking standard, respectively. 
 
3.5.2. HPLC Analysis of Adulterated Plant Materials 
To evaluate the hypothesis that the spiking standard preferentially 
deposited onto the glass vials and not onto the plant material, the vials used to 
make the adulterated materials were analyzed by HPLC for the residual 
standards. The resulting amounts of material recovered from this analysis are 
summarized in Table 6. Salvinorin A was not spiked onto Salvia divinorum as it 
has been previously performed in the literature (51). The percent recovery of 
salvinorin A from the empty vials was approximately 0%, 12%, and 22% at each 
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respective concentration level on the three different matrices of S. officinalis, 
Kratom, and Dream Herb. This result supports the hypothesis that some of the 
spiking standard was left behind in the vials used to make the adulterated 
materials.  
Table 6. HPLC recoveries of vials after spiking plant materials with 
salvinorin A, salvinorin B, and SB-EME. ND = not detected. 
Matrix Spiked Conc. (mg/g) 
Sal A 
(µg) 
Sal A % 
Yield 
Sal B 
(µg) 
Sal B% 
Yield 
SB-EME 
(µg) 
SB-EME 
% Yield 
Salvia 
officinalis 
3.4 ND 0.0 5.9 57.7 ND 0.0 
15.0 3.3 7.4 9.0 20.0 ND 0.0 
40.0 20.6 17.1 129.6 108.0 25.6 21.3 
Salvia 
divinorum 
3.4 - - 2.9 28.0 ND 0.0 
15.0 - - 1.4 3.2 ND 0.0 
40.0 - - 94.7 79.0 36.7 30.6 
Kratom 
3.4 ND 0.0 3.9 37.9 2.0 19.4 
15.0 8.4 18.7 3.3 7.4 ND 0.0 
40.0 28.1 23.5 121.1 100.9 58.8 49.0 
Dream 
Herb 
3.4 ND 0.0 5.2 51.0 1.7 17.1 
15.0 3.9 8.7 ND 0.0 ND 0.0 
40.0 31.1 25.9 116.1 96.7 76.3 63.6 
Averages 
3.4 ND 0.0 4.5 43.7 0.9 9.1 
15.0 5.2 11.6 3.4 7.7 ND 0.0 
40.0 26.6 22.2 115.4 96.2 49.4 41.1 
 
The results for salvinorin B and SB-EME showed less of a consistent trend 
of increasing spiking concentration leading to increased recovery from the empty 
vials. These two standards showed little to no recovery at the 15 mg/g level 
compared to the 3.4 mg/g and 40 mg/g levels. This is because salvinorin B and 
SB-EME were originally spiked onto a bulk portion of leaves at the 15 mg/g level 
and then portioned out for analysis into different, smaller vials. These samples 
were made in bulk at the 15 mg/g concentration level for other experiments that 
 
 
70 
fell outside the scope of this thesis. This resulted in the extraction of the vials that 
were not the original vial used to make the adulterated samples. The other two 
concentration levels were made similarly to salvinorin A, extracting the original 
vial used for the adulteration. This accidental inconsistency still supports the 
hypothesis that a portion of the material is being deposited in the vials, as the 
vials that were not used to make the adulterated plant materials ended up with 
lower recoveries. The recovery at the 3.4 mg/g level was an average of 44% for 
salvinorin B and an average of 9% for SB-EME. The recovery at the 15 mg/g 
level was an average of 7% for salvinorin B and 0% for SB-EME. At the 40 mg/g 
level, the recovery for salvinorin B was an average of 96% and for SB-EME was 
an average of 41%.  
Therefore, it can be concluded that major portions of the spiking standards 
were recovered from the glass vials after the colorimetric assay with Ehrlich’s 
reagent. This could be the reason as to why very little color was seen during the 
reaction, even with the Salvia divinorum samples, as the inherent salvinorin 
compounds could have been extracted from the leaves and deposited in the 
vials. 
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4. CONCLUSIONS 
 The extraction of salvinorin A from Salvia divinorum was a straightforward 
process, which makes it easy to see why many “Salvia” products on the Internet 
are extracts or fortified leaves (46). The synthesis to salvinorin B also proceeded 
simply, at room temperature, with cheap, common reagents. This reaction could 
be easily performed outside of a laboratory environment. In addition, the work-up 
procedure gave an increase in purity, allowing some of the contaminants from 
the extraction to be filtered away. The potential for clandestine chemists to 
experiment with salvinorin B to make other derivatives is a real risk, given the 
current environment for synthetic cannabinoids and bath salts flooding the drug 
market (1).  
However, the synthesis of the ether derivatives SB-MME and SB-EME are 
less likely to become popular for several reasons. First, the chloroalkyl ethers 
necessary to make the ethers are specialty chemicals, with no consumer 
equivalent that would allow for easy access. The chemicals would have to be 
diverted from the chemical or academic industries, which would not allow for 
large-scale synthesis. In addition, the chloroalkyl ethers used in this study are 
known carcinogens, which require strict safe handling procedures. The resulting 
condensation reactions have low yields when not using dry or freshly distilled 
solvents. However, given the higher potency of the ethers compared to salvinorin 
A, it is plausible that clandestine chemists would still accept a mixture for 
recreational use. 
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The accuracy of the HPLC method was found to be approximately 88% for 
salvinorin B, and was approximately 100% for the recovery of SB-EME. 
However, given the known matrix issues, the error in these values is not well 
defined. Using the first set of SB-EME calibration standards, the method had an 
absolute range of error from 0.03 – 11.79%. The analytical repeatability within 
each set of SB-EME standards was below 9% RSD for triplicate injections. The 
intermediate precision between the three sets of SB-EME standards was <12% 
RSD. The linearity was 0.9993, indicating good linearity over the range of the SB-
EME standards. The range covered two orders of magnitude from 0.0005 – 
0.064 mg/mL, or a mass of 0.038 µg – 4.8 µg. The LOD was determined to be 
0.0005 mg/mL, or 0.038 µg of SB-EME, and the LOQ was determined to be 
0.0015 mg/mL, or 0.113 µg. The selectivity of the method was more challenging, 
as significant matrix effects were seen when using Salvia officinalis as the blank 
matrix. However, the purified solutions of SB-EME had baseline resolution from 
salvinorin A and salvinorin B, which allows for easy qualitative distinction if 
adulterated samples are suspected. It will be important to evaluate the 
contributions from the matrix with this HPLC method. 
UV/Vis analysis was an easy, quick method of characterization. The 
UV/Vis spectrum for SB-EME was distinguishable from both salvinorin A and 
salvinorin B. 
The colorimetric assay with Ehrlich’s reagent also provided a red-orange 
result with salvinorin B and SB-EME. While this does not provide differentiation in 
 
 
73 
the field, it does allow all materials related to Salvia divinorum to be identified and 
collected for further analysis in the lab. This colorimetric analysis will allow easy 
separation from common kitchen herbs, such as mint, basil, and sage. Since a 
confirmatory test will have to be performed in the lab according to SWGDRUG 
guidelines, the use of Ehrlich’s reagent as a screening test will help the analyst 
choose the appropriate confirmatory method. 
Characterization of the colored species in the assay with Ehrlich’s reagent 
was performed with UV/Vis, HPLC, and NMR. The UV/Vis analysis showed a 
new peak at 500 nm in the aqueous layer, which would correspond to a red-
orange color. HPLC analysis revealed a new, highly retained peak from the DCM 
layer of the assay. 1H NMR analysis revealed that the backbone of the 
salvinorins was not stable in acid, and the molecule that creates the color was 
likely a decomposition product. There were still two aromatic protons present, 
however, which leads to the hypothesis that the third proton has reacted with the 
pDMAB in Ehrlich’s reagent. This supports the proposed mechanism for 
salvinorin A and related compounds proceeding by an electrophilic aromatic 
substitution of the furan ring.  
The spiking experiment to create adulterated samples gave the opposite 
color result from what was expected. With the addition of more furan containing 
compounds, the red-orange color was expected to intensify. However, the color 
result decreased as the concentration of spiked standard increased. It is 
hypothesized that this result is due to the spiking procedure used, as the solvent 
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added to the leaves potentially extracted out the inherent salvinorin A in the 
leaves and deposited both salvinorin A and the spiking standard onto the glass of 
the vial. HPLC analysis of the leftover vials after the colorimetric assay confirmed 
recoveries of the spiking compounds up to an average of 22% for salvinorin A, 
96% for salvinorin B, and 41% for SB-EME over all matrices.  
In conclusion, salvinorin B ethoxymethyl ether can be detected in the field 
through the use of Ehrlich’s reagent as a colorimetric assay. Further laboratory 
tests, including HPLC and UV/Vis, were shown to easily distinguish the ether 
derivative from salvinorin A and B. If clandestine chemists attempt synthetic 
derivatives of salvinorin A, they should be easily detectable by the methods 
described. 
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5. FUTURE DIRECTIONS 
Given the new insights into the mechanism of salvinorin A with Ehrlich’s 
reagent, it would be interesting to return to the original proposal of the LSD 
mechanism. For one, the acid stability of LSD should be assessed. It is likely that 
the LSD molecule will also be broken apart by the strong acid in the solution of 
Ehrlich’s reagent. Therefore, the final 2:1 adduct would have a different structure 
than what was originally proposed. In addition, the literature behind the 
mechanism dates back to 1989, and contains very little data to support the 
mechanism (55). It would be worthwhile to update this proposed mechanism to 
provide more understanding to a colorimetric assay in frequent use in forensic 
labs.  
Another colorimetric assay that would be interesting to pursue for the 
analysis of salvinorin A and derivatives is the Duquenois-Levine test. This test 
uses vanillin as a reagent to react with the THC in marijuana. Vanillin is used 
frequently in TLC, and was used in this research to color the salvinorin 
derivatives red. It has been reported that analysis of Salvia divinorum with the 
Duquenois-Levine Test turns the top aqueous layer a wine-red color (61). It 
would be useful to validate this assay for use with Salvia divinorum to add as a 
complementary test. Given that the Duquenois-Levine test is already in use by 
forensic labs, there should be little barrier to implementation.  
The result with Dream Herb, where the Ehrlich’s reagent turned a brighter 
yellow, requires further investigation. It is possible that 9α-acetoxyzexbrevin 
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reacts with Ehrlich’s reagent or potentially another compound from Dream Herb 
not yet identified. UV/Vis analysis would be useful to use in this case, as the 
distinction between the light yellow Ehrlich’s reagent and the brighter yellow from 
Dream herb might be difficult to distinguish visually.  
Additional UV/Vis experiments on the colorimetric assay with Ehrlich’s 
reagent would be useful. The molar absorptivity of the colored intermediate 
would be useful characterization data to have. However, one important 
consideration would be determining the concentration of the colored intermediate 
in solution first. This is necessary to calculate the molar absorptivity using Beer’s 
Law. Insights into the kinetics of the reaction of salvinorin A and derivatives with 
Ehrlich’s reagent using UV/Vis or NMR would be interesting to investigate. In 
addition, UV/Vis could also be used to attempt to distinguish mixtures of 
salvinorin derivatives or plant materials adulterated with salvinorin derivatives. 
This would have the advantage of an analysis that is quicker and easier to use 
than HPLC. 
The colorimetric assay on adulterated materials has some opportunities 
for improvement. Initially, performing the reaction with Ehrlich’s reagent in the vial 
in which the plant materials were spiked would serve as a good control, as this 
would serve to show any influences by the plant matrices while ensuring all of the 
standard will be analyzed. Investigating the addition of an internal standard would 
help determine a more accurate percent recovery by HPLC. Finally, the method 
of spiking could also be optimized to avoid the influence of the deposition on the 
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glass vials. Perhaps a different type or volume of solvent, or different containers, 
such as plastic vials could avoid the loss of material onto the vial walls.   
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6. APPENDICES 
A.1. TLC of Salvinorin A, Salvinorin B, and SB-EME 
SA = salvinorin A, SB = salvinorin B. TLC conditions were 10% acetone/DCM, 
and visualized with a vanillin stain. 
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A.2. Salvinorin A NMR 
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A.3. Salvinorin B NMR 
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A.4. Salvinorin B Ethoxymethyl Ether NMR 
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A.5. HPLC Validation Raw Data Tables 
A.5.1. Accuracy Data Table 
Sample Ave Area (mAU*s) 
Std 
Dev 
% 
RSD 
Conc. 
(mg/mL) 
Total 
(mg) 
Ave 
(mg) 
Std 
Dev 
% 
RSD 
% 
Recovery 
Ave % 
Recovery 
S. 
officinalis/
Sal B 1 
8481.2 69.47 0.82 0.154 0.96 
0.99 0.02 2.12 
85.69 
87.83 
S. 
officinalis/
Sal B 2 
8794.7 74.34 0.85 0.160 1.00 88.86 
S. 
officinalis/
Sal B 3 
8804.7 117.47 1.33 0.160 1.00 88.96 
S. 
officinalis/
SB-EME 1 
5789.7 290.35 5.02 0.181 1.13 
1.13 0.01 0.91 
100.70 
100.04 
S. 
officinalis/
SB-EME 2 
5773.4 651.63 11.29 0.181 1.13 100.42 
S. 
officinalis/
SB-EME 3 
5692.1 580.84 10.20 0.178 1.11 99.01 
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A.5.2. SB-EME Standards Set 1 
Concentration 
(mg/mL) 
Set 1 
Area 
(mAU*s) 
Ave 
Area 
(mAU*s) 
StdDev %RSD Back Calculation % RE 
0.0005 
17.5 
17.13 1.19 6.96 
0.0003 -34.25 
18.1 0.0003 -30.49 
15.8 0.0003 -44.91 
0.0010 
33.8 
33.27 1.57 4.72 
0.0008 -16.05 
34.5 0.0009 -13.85 
31.5 0.0008 -23.26 
0.0015 
52.1 
53.33 1.88 3.53 
0.0014 -5.74 
55.5 0.0015 1.37 
52.4 0.0014 -5.11 
0.0020 
65.1 
65.53 2.48 3.78 
0.0018 -8.97 
68.2 0.0019 -4.11 
63.3 0.0018 -11.79 
0.0040 
140.1 
139.50 1.22 0.87 
0.0042 4.29 
138.1 0.0041 2.72 
140.3 0.0042 4.45 
0.0080 
270.4 
272.30 1.65 0.60 
0.0083 3.20 
273.2 0.0083 4.30 
273.3 0.0083 4.34 
0.0160 
573.7 
573.30 1.25 0.22 
0.0178 11.02 
574.3 0.0178 11.14 
571.9 0.0177 10.67 
0.0320 
1028.6 
1026.80 2.31 0.22 
0.0320 0.07 
1027.6 0.0320 -0.03 
1024.2 0.0319 -0.36 
0.0640 
2102.3 
2093.30 7.80 0.37 
0.0657 2.63 
2089.2 0.0653 1.98 
2088.4 0.0652 1.94 
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A.5.3. SB-EME Standards Set 2 
Concentration 
(mg/mL) 
Set 2 
Area 
(mAU*s) 
Ave 
Area 
(mAU*s) 
StdDev %RSD Back Calculation % RE 
0.0005 
19.4 
19.63 0.25 1.28 
0.0004 -22.33 
19.6 0.0004 -21.08 
19.9 0.0004 -19.20 
0.0010 
30.7 
29.53 2.02 6.84 
0.0007 -25.76 
27.2 0.0006 -36.74 
30.7 0.0007 -25.76 
0.0015 
53.2 
55.27 2.76 4.99 
0.0014 -3.44 
58.4 0.0016 7.43 
54.2 0.0015 -1.35 
0.0020 
73.7 
74.17 0.45 0.61 
0.0021 4.51 
74.2 0.0021 5.30 
74.6 0.0021 5.92 
0.0040 
113.1 
127.47 12.70 9.96 
0.0033 -16.87 
137.2 0.0041 2.02 
132.1 0.0039 -1.98 
0.0080 
292.2 
289.97 2.04 0.70 
0.0089 11.74 
289.5 0.0089 10.69 
288.2 0.0088 10.18 
0.0160 
628 
631.50 3.21 0.51 
0.0195 21.66 
634.3 0.0197 22.89 
632.2 0.0196 22.48 
0.0320 
1102.9 
1099.57 3.30 0.30 
0.0344 7.35 
1099.5 0.0342 7.02 
1096.3 0.0341 6.70 
0.0640 
2254.1 
2248.47 5.50 0.24 
0.0704 10.06 
2243.1 0.0701 9.52 
2248.2 0.0703 9.77 
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A.5.4. SB-EME Standards Set 3 
Concentration 
(mg/mL) 
Set 3 
Area 
(mAU*s) 
Ave 
Area 
(mAU*s) 
StdDev %RSD Back Calculation % RE 
0.0005 
15.8 
15.47 0.95 6.11 
0.0003 -44.91 
14.4 0.0002 -53.70 
16.2 0.0003 -42.41 
0.0010 
30.6 
29.17 1.56 5.36 
0.0007 -26.08 
29.4 0.0007 -29.84 
27.5 0.0006 -35.80 
0.0015 
44.8 
43.63 3.88 8.90 
0.0012 -21.00 
46.8 0.0012 -16.82 
39.3 0.0010 -32.50 
0.0020 
58.4 
60.13 1.58 2.63 
0.0016 -19.47 
60.5 0.0017 -16.18 
61.5 0.0017 -14.61 
0.0040 
114.5 
115.67 1.04 0.90 
0.0034 -15.77 
116.5 0.0034 -14.20 
116 0.0034 -14.59 
0.0080 
226.5 
228.80 3.40 1.48 
0.0069 -14.00 
227.2 0.0069 -13.73 
232.7 0.0071 -11.57 
0.0160 
485.6 
484.97 0.71 0.15 
0.0150 -6.24 
485.1 0.0150 -6.34 
484.2 0.0150 -6.51 
0.0320 
913 
913.53 1.19 0.13 
0.0284 -11.25 
914.9 0.0285 -11.07 
912.7 0.0284 -11.28 
0.0640 
1796.6 
1793.80 3.94 0.22 
0.0561 -12.35 
1795.5 0.0561 -12.40 
1789.3 0.0559 -12.71 
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A.5.5. SB-EME Standards Averages 
 
Concentration 
(mg/mL) 
Total 
Ave 
Area 
(mAU*s) 
Total 
StdDev 
Total % 
RSD 
0.0005 17.41 1.97 11.33 
0.0010 30.66 2.47 8.06 
0.0015 50.74 5.98 11.78 
0.0020 66.61 6.31 9.47 
0.0040 127.54 12.14 9.52 
0.0080 263.69 27.35 10.37 
0.0160 563.26 63.92 11.35 
0.0320 1013.30 81.22 8.01 
0.0640 2045.19 200.22 9.79 
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A.6. LOD/LOQ Raw Data Table 
Concentration 
(mg/mL) 
Set 1 
Area 
(mAU*s) 
S/N 
Set 2 
Area 
(mAU*s) 
S/N 
Set 3 
Area 
(mAU*s) 
S/N 
0.0005 
17.5 3.8 19.4 4.8 15.8 3.5 
18.1 4.4 19.6 4.2 14.4 3.6 
15.8 4.3 19.9 5.9 16.2 3.9 
0.0010 
33.8 6.7 30.7 6.7 30.6 7.0 
34.5 7.5 27.2 6.1 29.4 5.3 
31.5 6.4 30.7 6.7 27.5 6.0 
0.0015 
52.1 10.2 53.2 10.9 44.8 9.4 
55.5 12.3 58.4 10.8 46.8 9.7 
52.4 12.0 54.2 12.2 39.3 7.9 
0.0020 
65.1 12.8 73.7 14.7 58.4 12.4 
68.2 12.8 74.2 13.7 60.5 11.9 
63.3 12.9 74.6 15.7 61.5 14.2 
0.0040 
140.1 26.4 113.1 31.7 114.5 23.3 
138.1 30.4 137.2 33.2 116.5 26.1 
140.3 30.7 132.1 29.4 116.0 23.7 
0.0080 
270.4 58.8 292.2 56.2 226.5 48.1 
273.2 50.1 289.5 56.4 227.2 51.1 
273.3 55.2 288.2 62.0 232.7 47.3 
0.0160 
573.7 93.6 628.0 111.7 485.6 91.5 
574.3 106.1 634.3 123.9 485.1 84.5 
571.9 118.8 632.2 112.9 484.2 100.6 
0.0320 
1028.6 153.5 1102.9 167.7 913.0 157.1 
1027.6 151.6 1099.5 196.2 914.9 135.1 
1024.2 185.7 1096.3 183.4 912.7 133.8 
0.0640 
2102.3 307.5 2254.1 252 1796.6 212.1 
2089.2 231.6 2243.1 233.5 1795.5 193.6 
2088.4 267.2 2248.2 236.2 1789.3 210.3 
 
 
 
 
 
 
 
88 
A.7. UV/Vis Spectra 
A.7.1. Salvinorin A UV/Vis Spectrum 
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A.7.2. Salvinorin B UV/Vis Spectrum 
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A.7.3. SB-EME UV/Vis Spectrum 
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A.8. 1H NMR of Colorimetric Assay with Ehrlich’s Reagent 
A.8.1. 1H NMR Stack 
Salvinorin B (blue), DCM Layer of Salvinorin B after Reaction with Ehrlich’s 
Reagent (red), and Salvinorin B after Acid Wash (green).  
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A.8.2. 1H NMR of Salvinorin B after Acid Wash 
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A.8.3. pDMAB 1H NMR 
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A.8.4. 2D COSY 1H NMR of Salvinorin B after Reaction with Ehrlich’s Reagent 
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